ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novartis sets sights on potential COVID-19 antivirals from Molecular Partners
October 30, 2020Swiss pharma company Novartis has inked an option and license agreement with Molecular Partners to develop, manufacture and commercialise the latter’s anti-COVID-19 DARPin programme. -
Novartis and Molecular Partners collaborate on anti-Covid-19 programme
October 30, 2020Novartis and Molecular Partners have entered into a collaboration in the form of an option and license agreement for the latter’s anti-COVID-19 DARPin programme.
Pharma Sources Insight January 2025
